The Neuropathology Core (Core D) of the Johns Hopkins Alzheimer's Disease Research Center (ADRC) has two overarching goals, one related to the analysis and distribution of brain tissue and other specimens from subjects in the ADRC, and the other related to the analysis of genetically engineered mouse models by investigators associated with the ADRC.
The specific aims of Core D are as follows: (1) to arrange and perform autopsies on clinically well-characterized subjects enrolled through the JHMI ADRC and assist with consensus diagnoses on subjects associated with the ADRC (comprised of the Clinic Cohort and the BLSA Cohort). (2) to accession and store optimally prepared tissues from the autopsies and to make these specimens available to investigators associated with the ADRC and at other collaborating institutions. (3) to accession and store samples of biological fluids and DNA obtained pre- and postmortem from subjects in the ADRC. (4) to facilitate APOE genotyping on participants in the ADRC. (5) to support the assessment of genetically engineered mouse models relevant to Alzheimer's disease (AD) and related disorders, (6) to collaborate with the medical and research community outside of Johns Hopkins by providing assistance with postmortem diagnoses of AD and other types of dementia, and (7) to train basic investigators and clinical neuroscientists in the morphological and diagnostic concepts relevant to AD, to other types of dementias and neurodegenerative disorders.
The Johns Hopkins Alzheimer's Disease Research Center (ADRC) will address many of the topics important to dementia research, with a particular focus on the understanding the earliest phases of Alzheimer's disease (AD). This approach is important if we are ultimately going to be able to diagnose and treat AD as early as possible. The ADRC fosters interactions among scientists who are pursuing this overarching theme.
|Geiger, Joshua T; Ding, Jinhui; Crain, Barbara et al. (2016) Next-generation sequencing reveals substantial genetic contribution to dementia with Lewy bodies. Neurobiol Dis 94:55-62|
|Mata, Ignacio F; Leverenz, James B; Weintraub, Daniel et al. (2016) GBA Variants are associated with a distinct pattern of cognitive deficits in Parkinson's disease. Mov Disord 31:95-102|
|Gross, Alden L; Mungas, Dan M; Leoutsakos, Jeannie-Marie S et al. (2016) Alzheimer's disease severity, objectively determined and measured. Alzheimers Dement (Amst) 4:159-168|
|Karch, Celeste M; Ezerskiy, Lubov A; Bertelsen, Sarah et al. (2016) Alzheimer's Disease Risk Polymorphisms Regulate Gene Expression in the ZCWPW1 and the CELF1 Loci. PLoS One 11:e0148717|
|Forrester, Sarah N; Gallo, Joseph J; Smith, Gwenn S et al. (2016) Patterns of Neuropsychiatric Symptoms in Mild Cognitive Impairment and Risk of Dementia. Am J Geriatr Psychiatry 24:117-25|
|Huo, Yuankai; Plassard, Andrew J; Carass, Aaron et al. (2016) Consistent cortical reconstruction and multi-atlas brain segmentation. Neuroimage 138:197-210|
|Gruenewald, Tara L; Tanner, Elizabeth K; Fried, Linda P et al. (2016) The Baltimore Experience Corps Trial: Enhancing Generativity via Intergenerational Activity Engagement in Later Life. J Gerontol B Psychol Sci Soc Sci 71:661-70|
|Oh, Esther S; Sieber, Frederick E; Leoutsakos, Jeannie-Marie et al. (2016) Sex Differences in Hip Fracture Surgery: Preoperative Risk Factors for Delirium and Postoperative Outcomes. J Am Geriatr Soc 64:1616-21|
|Yesavage, Jerome A; Taylor, Joy L; Friedman, Leah et al. (2016) Principal components analysis of agitation outcomes in Alzheimer's disease. J Psychiatr Res 79:4-7|
|McCutcheon, Sarah T; Han, Dingfen; Troncoso, Juan et al. (2016) Clinicopathological correlates of depression in early Alzheimer's disease in the NACC. Int J Geriatr Psychiatry 31:1301-1311|
Showing the most recent 10 out of 602 publications